Billions of pills are swallowed every year in the U.S., and billions more are consumed worldwide. Yet, pharmaceutical companies, government agencies, and physicians downplay the risk. Many consumers, oblivious to the real danger, risk their lives each and every day by taking 2, 3, 4, or more drugs with potentially deadly consequences.
If you're taking prescription drugs - you need to read this book. If you want a primer on the inner workings of the pharmaceutical marketing machine - this book is for you.
The author's compare and contrast the role of the FDA before the 1990's and the 1990's & beyond. Before the 90's the FDA / Pharmaceutical industry relationship was adversarial, with drug safety dictating long, tedious clinical testing. In 1992, the world changed with the Prescription Drug User Fee Act (PDUFA). Then in 1997, the Food & Drug Modernization Act (FDAMA) really blasted open the doors for the pharmaceutical industry. FDAMA allowed actively promoting off-label drug use and fast-tracking of trials.
Death by Prescription also breaks down the inner workings of the pharmaceutical marketing machine, whereby medical knowledge was hijacked by the pharmaceutical (and medical device) manufacturers. Statistics are skewed by blinding people through relative risk as opposed to the real picture shown by absolute risk.
Death by Prescription is an absolute page turner, peppered with case histories and heart-retching stories that blow apart the industry's efforts to conceal the real dangers posed by drugs.
Opportunity is in the air. Pharmaceuticals are facing huge uphill battles as they confront dwindling drug pipelines, devastating lawsuits, and are struggling to cope with the dawn of genetic medicine which will destroy mass-markets.
Michael Davis - Editor, Byvation